664 related articles for article (PubMed ID: 16287955)
1. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
Alexander JH; Hafley G; Harrington RA; Peterson ED; Ferguson TB; Lorenz TJ; Goyal A; Gibson M; Mack MJ; Gennevois D; Califf RM; Kouchoukos NT;
JAMA; 2005 Nov; 294(19):2446-54. PubMed ID: 16287955
[TBL] [Abstract][Full Text] [Related]
2. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.
Conte MS; Bandyk DF; Clowes AW; Moneta GL; Seely L; Lorenz TJ; Namini H; Hamdan AD; Roddy SP; Belkin M; Berceli SA; DeMasi RJ; Samson RH; Berman SS;
J Vasc Surg; 2006 Apr; 43(4):742-751; discussion 751. PubMed ID: 16616230
[TBL] [Abstract][Full Text] [Related]
3. The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.
Alexander JH; Ferguson TB; Joseph DM; Mack MJ; Wolf RK; Gibson CM; Gennevois D; Lorenz TJ; Harrington RA; Peterson ED; Lee KL; Califf RM; Kouchoukos NT;
Am Heart J; 2005 Oct; 150(4):643-9. PubMed ID: 16209958
[TBL] [Abstract][Full Text] [Related]
4. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
Magee MJ; Alexander JH; Hafley G; Ferguson TB; Gibson CM; Harrington RA; Peterson ED; Califf RM; Kouchoukos NT; Herbert MA; Mack MJ;
Ann Thorac Surg; 2008 Feb; 85(2):494-9; discussion 499-500. PubMed ID: 18222251
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of edifoligide.
Desai ND; Fremes SE
JAMA; 2006 Apr; 295(13):1514; author reply 1514-5. PubMed ID: 16595752
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of edifoligide.
Lau GT; Kritharides L
JAMA; 2006 Apr; 295(13):1513-4; author reply 1514-5. PubMed ID: 16595750
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of edifoligide.
Parolari A; Alamanni F; Tremoli E; Biglioli P
JAMA; 2006 Apr; 295(13):1513; author reply 1514-5. PubMed ID: 16595751
[No Abstract] [Full Text] [Related]
8. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.
Conte MS; Lorenz TJ; Bandyk DF; Clowes AW; Moneta GL; Seely BL
Vasc Endovascular Surg; 2005; 39(1):15-23. PubMed ID: 15696244
[TBL] [Abstract][Full Text] [Related]
9. Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.
Lopes RD; Williams JB; Mehta RH; Reyes EM; Hafley GE; Allen KB; Mack MJ; Peterson ED; Harrington RA; Gibson CM; Califf RM; Kouchoukos NT; Ferguson TB; Lorenz TJ; Alexander JH
Am Heart J; 2012 Sep; 164(3):379-386.e1. PubMed ID: 22980305
[TBL] [Abstract][Full Text] [Related]
10. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial.
Goldman S; Sethi GK; Holman W; Thai H; McFalls E; Ward HB; Kelly RF; Rhenman B; Tobler GH; Bakaeen FG; Huh J; Soltero E; Moursi M; Haime M; Crittenden M; Kasirajan V; Ratliff M; Pett S; Irimpen A; Gunnar W; Thomas D; Fremes S; Moritz T; Reda D; Harrison L; Wagner TH; Wang Y; Planting L; Miller M; Rodriguez Y; Juneman E; Morrison D; Pierce MK; Kreamer S; Shih MC; Lee K
JAMA; 2011 Jan; 305(2):167-74. PubMed ID: 21224458
[TBL] [Abstract][Full Text] [Related]
11. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.
Harskamp RE; Alexander JH; Schulte PJ; Brophy CM; Mack MJ; Peterson ED; Williams JB; Gibson CM; Califf RM; Kouchoukos NT; Harrington RA; Ferguson TB; Lopes RD
JAMA Surg; 2014 Aug; 149(8):798-805. PubMed ID: 25073921
[TBL] [Abstract][Full Text] [Related]
12. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
Mann MJ; Whittemore AD; Donaldson MC; Belkin M; Conte MS; Polak JF; Orav EJ; Ehsan A; Dell'Acqua G; Dzau VJ
Lancet; 1999 Oct; 354(9189):1493-8. PubMed ID: 10551494
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery.
Lopes RD; Hafley GE; Allen KB; Ferguson TB; Peterson ED; Harrington RA; Mehta RH; Gibson CM; Mack MJ; Kouchoukos NT; Califf RM; Alexander JH
N Engl J Med; 2009 Jul; 361(3):235-44. PubMed ID: 19605828
[TBL] [Abstract][Full Text] [Related]
14. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
Willemsen LM; Janssen PWA; Peper J; Soliman-Hamad MA; van Straten AHM; Klein P; Hackeng CM; Sonker U; Bekker MWA; von Birgelen C; Brouwer MA; van der Harst P; Vlot EA; Deneer VHM; Chan Pin Yin DRPP; Gimbel ME; Beukema KF; Daeter EJ; Kelder JC; Tijssen JGP; Rensing BJWM; van Es HW; Swaans MJ; Ten Berg JM
Circulation; 2020 Nov; 142(19):1799-1807. PubMed ID: 32862716
[TBL] [Abstract][Full Text] [Related]
15. External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial.
Goldstein DJ; Puskas JD; Alexander JH; Chang HL; Gammie JS; Marks ME; Iribarne A; Vengrenyuk Y; Raymond S; Taylor BS; Yarden O; Orion E; Dagenais F; Ailawadi G; Chu MWA; DiMaio JM; Narula J; Moquete EG; O'Sullivan K; Williams JB; Crestanello JA; Jessup M; Rose EA; Scavo V; Acker MA; Gillinov M; Mack MJ; Gelijns AC; O'Gara PT; Moskowitz AJ; Bagiella E; Voisine P
JAMA Cardiol; 2022 Aug; 7(8):808-816. PubMed ID: 35675092
[TBL] [Abstract][Full Text] [Related]
16. Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials.
Cao C; Manganas C; Horton M; Bannon P; Munkholm-Larsen S; Ang SC; Yan TD
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):255-61. PubMed ID: 22871565
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
[TBL] [Abstract][Full Text] [Related]
19. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial.
Kulik A; Voisine P; Mathieu P; Masters RG; Mesana TG; Le May MR; Ruel M
Ann Thorac Surg; 2011 Oct; 92(4):1284-90; discussion 1290-1. PubMed ID: 21958773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
